SciNeuro Pharmaceuticals: Valuation, Funding & Investors
SciNeuro Pharmaceuticals is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases. Since its founding in 2020, SciNeuro has built a portfolio of pipeline programs staged from discovery to clinical development by addressing three key disease-driving mechanisms of neurodegeneration – neurovascular inflammation, proteinopathy, and immune response.
Leadership & Board
- Current Number of Employees
- 32
- Current LinkedIn Followers
- 3,072
Latest Estimated Valuation
- Total Amount Raised
- $53M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $53M
- Latest Funding Round
- Investment
Employee Trend
SciNeuro Pharmaceuticals had 32 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
SciNeuro Pharmaceuticals had 3,072 followers as of November 16, 2026. The number of followers increased by 7 (0.23%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Dec 04, 2025 | Investment | $53.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| ARCH Venture Partners | Investment |
| LAV | Investment |
Similar Companies
A snapshot of private companies similar to SciNeuro Pharmaceuticals, helping you discover and navigate related company profiles.
Related News and Analysis








